Sunrest Lifescience Limited

₹35.70As of Sun 8 Nov 2026, 12:00 UTC
NSE:SUNRESTHealthcare
Country India
PE (Fwd) •••
TSR 3Y CAGR (18.93%)
Div yield —
ROE 31.20%
Medical (Pharmaceuticals)
Beta (5Y) 0.10
PE TTM 3.723
TSR TTM (21.83%)
Mkt cap ₹153.2M
ROIC 16.12%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹43
19.71%
(80.53%)
Hold 4|9|1|3|4
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.42
0.43
0.45
0.50
24.47%
20.84%
19.30%
19.49%
Revenue₹M
9.018
9.512
10.02
10.41
4.24%
6.94%
13.03%
13.07%
Peers (US$1.622M)
Cap (US$)
PE
8.858M
43.29x
7.067M
16.83x
1.616M
—
Capital
TTM
5Y
10Y
Leveragex
0.444
1.247
0.814
EBIT/Intx
1.640
0.276
0.301
Own earn%
(11.73)
28.16
25.07
Sh yield%
31.34
45.98
46.23
Owners
Insiders/Inst%
12.52
46.43
Short interest%
3.05
SBC / revenue%
4.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
17–21
$1 testx
−0.3
Incr. ROIC%
1